- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: SoC: cyclophosphamide, bortezomib, and Dexamethasone (CyBorD)
Total 787 results
-
Bristol-Myers SquibbTerminatedMultiple MyelomaUnited States, Italy, France, Spain
-
Bristol-Myers SquibbExelixisCompletedAdvanced Cancer, Various, NOSUnited States
-
M.D. Anderson Cancer CenterWithdrawn
-
University of Wisconsin, MadisonCompletedMantle Cell LymphomaUnited States
-
Tanja Andrea GruberRecruitingAcute Lymphoblastic Leukemia, Pediatric | Refractory Acute Lymphoblastic Leukemia | Relapsed Acute Lymphoblastic LeukemiaUnited States
-
RenJi HospitalThe First Affiliated Hospital with Nanjing Medical University; The First Affiliated... and other collaboratorsRecruiting
-
GlaxoSmithKlineActive, not recruiting
-
University of Heidelberg Medical CenterCompleted
-
Keio UniversityCompletedAcute Lymphoblastic Leukemia | Myelodysplastic Syndrome | Acute Myelogenous Leukemia | Chronic Myelogenous LeukemiaJapan
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRefractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Recurrent Cutaneous Melanoma | Recurrent Malignant Female Reproductive System Neoplasm | Refractory Malignant Female Reproductive System Neoplasm | Recurrent Lip and Oral Cavity Carcinoma | Recurrent Malignant Endocrine... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingDS Stage I Multiple Myeloma | DS Stage II Multiple Myeloma | DS Stage III Multiple MyelomaUnited States, Saudi Arabia, Puerto Rico
-
Stichting European Myeloma NetworkJanssen PharmaceuticaRecruitingMultiple MyelomaAustria, Greece, Italy, Netherlands, Germany
-
The First Affiliated Hospital with Nanjing Medical...Recruiting
-
University of Heidelberg Medical CenterActive, not recruiting
-
Shanghai General Hospital, Shanghai Jiao Tong University...Unknown
-
Mayo ClinicRecruitingPlasma Cell MyelomaUnited States
-
Nantes University HospitalJanssen PharmaceuticaNot yet recruiting
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, Netherlands, Belgium, Korea, Republic of, United Kingdom, Sweden, Denmark, Italy, Japan, Germany, France, Spain, Australia, Israel, Poland, Greece
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, Belgium, Germany, Netherlands, Israel, Spain, Saudi Arabia, France
-
Cancer Trials IrelandCompleted
-
University of Heidelberg Medical CenterSanofi; KKS Netzwerk; Deutsche Studiengruppe Multiples Myelom (DSMM)Recruiting
-
University of Heidelberg Medical CenterJanssen Research & Development, LLC; Deutsche Studiengruppe Multiples Myelom...Recruiting
-
PETHEMA FoundationGlaxoSmithKlineRecruitingMultiple MyelomaSpain
-
TakedaActive, not recruiting
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaCanada, United States, Israel, Czechia, Turkey, Germany, United Kingdom, Japan, Netherlands, France, Brazil, Poland, Spain
-
SanofiActive, not recruitingPlasma Cell MyelomaMexico, Sweden, Poland, France, Czechia, Greece, Taiwan, Lithuania, Portugal, Spain, Australia, Italy, New Zealand, Russian Federation, Turkey, Japan, United States, Belgium, China, Denmark, Germany
-
Merck Sharp & Dohme LLCCompleted
-
University of ArkansasWithdrawn
-
Ruijin HospitalUnknownDiffuse Large B-cell LymphomaChina
-
Dana-Farber Cancer InstituteBristol-Myers SquibbNo longer availableMultiple Myeloma | Multiple Myeloma in RelapseUnited States
-
National Cancer Institute (NCI)WithdrawnRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Bristol-Myers SquibbCompleted
-
Omar Nadeem, MDJanssen, LPRecruitingMultiple Myeloma | High-risk Smoldering Multiple MyelomaUnited States
-
University of ChicagoRecruiting
-
Boston Medical CenterMillennium Pharmaceuticals, Inc.Completed
-
University of ArkansasWithdrawn
-
University of Maryland, BaltimoreUniversity of Maryland Greenebaum Cancer CenterCompleted
-
University of Maryland, BaltimoreCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedMultiple MyelomaUnited States
-
French Innovative Leukemia OrganisationHoffmann-La RocheCompletedMantle Cell LymphomaFrance
-
University Hospital TuebingenCompletedRelapsed or Refractory Multiple MyelomaGermany
-
Fred Hutchinson Cancer CenterNational Heart, Lung, and Blood Institute (NHLBI)RecruitingHIV Infection | Hematopoietic and Lymphoid Cell Neoplasm | Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Acute Erythroid Leukemia | Acute Megakaryoblastic Leukemia | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Myelodysplastic Syndrome With Excess Blasts | Chronic Myelogenous Leukemia, BCR-ABL1... and other conditionsUnited States
-
Indiana UniversityWithdrawnAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | Acute Lymphoblastic Leukemia, Adult | Bone Marrow Transplant ComplicationsUnited States
-
University of MiamiTerminatedLymphoma | Follicular Lymphoma | Marginal Zone LymphomaUnited States
-
Masonic Cancer Center, University of MinnesotaTerminated
-
Mayo ClinicCompletedMultiple Myeloma | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)TerminatedMultiple MyelomaUnited States
-
National Health Research Institutes, TaiwanNational Taiwan University Hospital; Mackay Memorial Hospital; Sun Yat-sen University and other collaboratorsTerminatedOral Cavity Cancer
-
Memorial Sloan Kettering Cancer CenterCompletedLeukemia | Myelodysplastic Syndrome | Chronic Myelogenous Leukemia | Non-Hodgkins Lymphoma | Hodgkins LymphomaUnited States
-
Masonic Cancer Center, University of MinnesotaCompleted